Cydan is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential. Cydan focuses on selecting promising assets with well-understood biology and proof-of-concept data in in vivo models from academia, industry and other sources. Data generated during a rigorous de-risking process enables formation of stand-alone companies and strategic partnerships.

Biotechnology

Education

Cydan

Cydan's headquarters in Cambridge, MA, United States

Chris Adams

ShiYin Foo

Imran Babar

Joel S. Marcus

Sandip K. Agarwala

Mette Kirstine Agger

Barbara J. Dalton

Matt McAviney

Description

People

Jobs